Notably, tumor vascularization was also significantly impaired after anti-CSFR1 treatment, as assessed by staining for CD31, a marker of endothelial cells, indicating a critical role of macrophages in promoting tumor neo-angiogenesis (Figure 3D, lower panels). Here, PECAM1 is linked to neoplasm.